Utility of Lung Ultrasonography as a Predictor of Fast Track Extubation

Utility of Lung Ultrasonography as a Predictor of Fast Track Extubation in Pediatric Cardiac Surgeries An Observational Study

Fast-tracking in cardiac surgery refers to early extubation to reduce costs and perioperative morbidity. The use of lung ultrasound is recently accepted as a tool in the assessment of several lung conditions. The aim of this study was to assess the use of lung ultrasound score as a quantitative method to assist in the decision of early extubation.

Study Overview

• Status: Completed
• Conditions: Exta Vascular Lung Water
• Intervention / Treatment: Diagnostic test: Lung ultrasound examination

Detailed Description

background: Fast-tracking in cardiac surgery refers to early extubation to reduce costs and perioperative morbidity. The use of lung ultrasound is recently accepted as a tool in the assessment of several lung conditions. The aim of this study was to assess the use of lung ultrasound score as a quantitative method to assist in the decision of early extubation.

Methedology: in this prospective, observational study, 45 pediatric patients who will go elective repair of congenital acyanotic heart diseases were included and were examined with Lung ultrasound together with arterial blood gases preoperative and postoperative and given a score range from 0-3 according to number of B lines in each region and sensitivity of post-operative lung ultrasound score to extubation within 6 hours was examined Demographic data: Patients' name, age, sex, diagnosis, relevant medical and surgical history. And Assessment data: Baseline arterial blood gases and lung ultrasound score assessment after induction of anesthesia and at the end of surgery.

Primary outcome will be the sensitivity of lung ultrasound scores immediately at the end of pediatric cardiac operation in prediction of extubation. and Secondary outcome will be correlation between lung ultrasound score and Po2/Fio2 ratio at the end of operation

• Study Type: Observational
• Enrollment (Actual): 45

Contacts and Locations

Study Locations

• Egypt
  • Cairo, Egypt
    • Kasr Alainy hospital
  • Cairo, Egypt, 11562
    • Kasr Al Ainy Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 6 months to 7 years (CHILD)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Patients suffering from Acyanotic congenital heart diseases.

Description

Inclusion Criteria:

• were Age 6 months to 7 years
• Patients suffering from Acyanotic congenital heart diseases.

Exclusion Criteria:

• Age is less than 6 months and more than 7 years,
• Preoperative mechanical ventilation,
• Preoperative inotropic support.,
• Trisomy 21,
• Patient with cyanotic heart diseases
• Coagulopathy INR >1.5

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
the sensitivity of lung ultrasound scores	the sensitivity of lung ultrasound scores immediately at the end of pediatric cardiac operation in prediction of extubation	immediately at the end of pediatric cardiac operation

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
correlation between lung ultrasound score and Po2/Fio2 ratio	correlation between lung ultrasound score and Po2/Fio2 ratio at the end of operation	immediatly at the end of pediatric cardiac operation until 6 hours post operative until extubatiioon

Collaborators and Investigators

• Sponsor: Kasr El Aini Hospital

Study record dates

Study Major Dates

• Study Start (ACTUAL): September 20, 2018
• Primary Completion (ACTUAL): June 1, 2022
• Study Completion (ACTUAL): August 1, 2022

Study Registration Dates

• First Submitted: March 25, 2022
• First Submitted That Met QC Criteria: April 5, 2022
• First Posted (ACTUAL): April 8, 2022

Study Record Updates

• Last Update Posted (ACTUAL): November 7, 2022
• Last Update Submitted That Met QC Criteria: November 4, 2022
• Last Verified: November 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: MS-235-2017

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: Yes
• product manufactured in and exported from the U.S.: No